myirislogo
24 October, 2019 03:08 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
Infosys 650.75 1.16
Tata Motors 132.65 0.57
Tata Power 60.80 2.62
Adani Ports 396.25 5.85
State Bank O 275.50 1.87
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Shilpa Medicare Limited
Shilpa Medicare Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs
BSE:530549NSE:SHILPAMEDBloomberg:SLPA@INReuters:SHME.BO
Market Lot: 1Face Value: 1ISIN Demat: INE790G01031
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
01-JAN-19 Shilpa Medicare has received U.S. Food and Drug Administration (USFDA) approval for its ANDA Irinotecan HCL Injection USP, 40 mg/2mL and 100 mg/5mL (20mg/mL) Single Dose Vials. Irinotecan injection is used in the treatment of patients with metastatic carcinoma of the colon or rectum. 16-NOV-18 Shilpa Medicare has received tentative approval from USFDA for its ANDA for Dimethyl Fumarate Delayed Release Capsules 120 mg & 240 mg. 11-JU...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Shilpa Medicare receives nod for Irinotecan HCL injection  -IRIS 01-Jan-19
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Dec-2015(9)31-Mar-2015 (12)31-Mar-2014 (12)
Net sales 4962.385654.025273.68
Other Income52.0254.5388.53
Total Income5014.405708.555362.21
Cost of goods sold3802.014288.744096.50
OPBDIT1212.391419.811265.71
PAT775.29841.81808.57
Gross Block---
Equity capital77.1077.1073.57
EPS (Rs.)-21.9421.98
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-15.50 - 48.276.19 - 19.25
Debt / Equity (x)---
Operating margin (% of OI)24.224.923.6
Net margin (% of OI)15.514.715.1
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
1st Floor, 10/ 80
Rajendra Gunj
Raichur
Karnataka-584 102
PHONE
(08532) 2350 06/ 2357 04
FAX
(08532) 2358 76
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer